More Patients with Severe Alcoholic Hepatitis Receiving Liver Transplants
Medical centers willing to perform transplants without mandated six-month wait Washington, DC (May 22, 2018) — Increasingly, liver transplant centers are changing a long-standing practice of delaying potentially life-saving liver transplantation for patients with severe alcoholic hepatitis until after they stopped drinking alcohol for six months, according to a new study scheduled for presentation at Digestive Disease […]
Experimental Drug Eases Effects of Gluten for Celiac Patients on Gluten-Free Diet
First proof-of-concept study shows AMG 714 (anti-IL-15 monoclonal antibody) potentially protects celiac patients from inadvertent gluten exposure Washington, DC (May 22, 2018) — An investigational new drug offers hope of relief for celiac disease patients who are inadvertently exposed to gluten while on a gluten-free diet. Findings of the first phase 2 study of a biologic […]
DNA-based Vaccine Treatment for Colorectal Cancer to Undergo First Human Study
Researchers have hope for immunotherapy approach that reinvigorates body’s natural defense against bowel cancer Washington, DC (May 22, 2018) — For the first time in humans, researchers will test a two-pronged approach to treat advanced stage colorectal cancer (CRC), potentially increasing life expectancy. Combining a DNA vaccine, which boosts the body’s immune response against tumors, with […]
Blue Dye Tablet Helps Identify Polyps During Colonoscopy
Oral-delayed release methylene blue aids in finding cancerous and pre-cancerous lesions Washington, D.C. (May 22, 2018) — Ingestion of a blue dye tablet during bowel prep for colonoscopy could be a significant advance in the early detection of colorectal cancer (CRC). When used in conjunction with colonoscopy, the blue dye increased adenoma detection rate (ADR) by […]
